Showing results (241-250 of 501) with videos related to
Sort By:
Pageof 51
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer TypesWilliam S Chen, Mohammed Alshalalfa, Shuang G Zhao, et al.Cancer Research|July 11, 2024
An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor ProgressionRaunak Shrestha, Lisa N Chesner, Meng Zhang, et al.Nature Communications|January 11, 2022
Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell statesHanbing Song, Hannah N W Weinstein, Paul Allegakoen, et al.NPJ Breast Cancer|August 26, 2017
Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancerCorey Speers, Shuang G Zhao, Ben Chandler, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2021
Blood Biomarker Landscape in Patients with High-risk Nonmetastatic Castration-Resistant Prostate Cancer Treated with Apalutamide and Androgen-Deprivation Therapy as They Progress to Metastatic DiseaseMatthew R Smith, Shibu Thomas, Michael Gormley, et al.Biorxiv : the Preprint Server for Biology|March 11, 2024
Canonical AREs are tumor suppressive regulatory elements in the prostateMichael A Augello, Xuanrong Chen, Deli Liu, et al.Cell|December 17, 2016
A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein ResponseBritt Adamson, Thomas M Norman, Marco Jost, et al.Nature|April 3, 2024
Improving prime editing with an endogenous small RNA-binding proteinJun Yan, Paul Oyler-Castrillo, Purnima Ravisankar, et al.NAR Cancer|August 28, 2023
Co-evolution of AR gene copy number and structural complexity in endocrine therapy resistant prostate cancerAndrej Zivanovic, Jeffrey T Miller, Sarah A Munro, et al.European Urology|February 5, 2019
Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder CancerJason A Efstathiou, Kent W Mouw, Ewan A Gibb, et al.Pageof 51